BMED
iShares Health Innovation Active ETF·ARCA
--
--(--)
--
--(--)
Key Stats
Assets Under Management
9.87MUSD
Fund Flows (1Y)
5.85MUSD
Dividend Yield
--
Discount/Premium to NAV
0.15%
Shares Outstanding
320.00K
Expense Ratio
0.55%
About iShares Health Innovation Active ETF
Issuer
BlackRock Fund Advisors
Brand
iShares
Inception Date
Sep 29, 2020
Structure
Open-Ended Fund
Index Tracked
--
Management Style
Active
Dividend Treatment
Distributes
Distribution Tax Treatment
Qualified dividends
Income Tax Type
Capital Gains
Max ST Capital Gains Rate
39.60%
Max LT Capital Gains Rate
20.00%
Primary Advisor
BlackRock Fund Advisors
Distributor
BlackRock Investments LLC
BMED focuses on total return by providing exposure to the broad health sciences group of industries, from R&D to production, and distribution of medical supplies in different fields including: dental, optical or pharmaceuticals. It also involves healthcare providers including health facilities and hospitals or those that provide related administrative, management or financial support. The fund reaches into non-human health as well, such as those focused on the survival of plants and animals. Firms that increase crop yields, taste, nutritional content or improve pet health are considered. BMED will include firms with varying market capitalizations with bias to small- and midcaps that may include foreign non-USD-denominated securities. The fund may also hold REITs that own hospitals and IPOs. During temporary defensive periods, the fund may invest up to 100% of its assets in liquid, short-term investments and can enter in credit default swaps for risk management.
Classification
Asset Class
Equity
Category
Sector
Focus
Health Care
Niche
Broad-based
Strategy
Active
Geography
Global
Weighting Scheme
Proprietary
Selection Criteria
Proprietary
Analysis
Sector
Healthcare
100.00%
Healthcare
100.00%
Asset
Holdings
Symbol
Ratio
JNJ
Johnson & Johnson
3.82%
GILD
Gilead Sciences
3.31%
EXAS
Exact Sciences
3.02%
MDT
Medtronic
2.99%
ROCHE HOLDING PAR AG
2.73%
BLK CSH FND TREASURY SL AGENCY
2.68%
Symbol
Ratio
GH
Guardant Health
2.42%
EW
Edwards Lifesciences
2.42%
BIIB
Biogen
2.41%
NOVARTIS
2.24%
Top 10 Weight 28.04%
10 Total Holdings
See all holdings
Related Funds
Seasonals
Volume Profile
Trade Flow Insight
Community Forum
Loading...
Related News
No articles available
You can ask Aime
No Data
